Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration

Abstract

This cross-sectional study found an overall decline in prescribing of fluoroquinolones after the release of FDA warnings. Understanding the association of physician and organizational characteristics with fluoroquinolone prescribing behavior may ultimately help to identify mechanisms to improve de-adoption.